KYNTRA BIO, INC. financial data

Symbol
KYNB on Nasdaq
Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 16 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 184% % 33%
Quick Ratio 5% % -58%
Debt-to-equity -192% % 6.2%
Return On Equity -175% % -878%
Return On Assets 122% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,046,827 shares -96%
Common Stock, Shares, Outstanding 4,047,000 shares 0.25%
Entity Public Float $21,000,000 USD -76%
Common Stock, Value, Issued $1,012,000 USD 0.3%
Weighted Average Number of Shares Outstanding, Basic 4,043,000 shares 1%
Weighted Average Number of Shares Outstanding, Diluted 4,043,000 shares 1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $6,440,000 USD -78%
Cost of Revenue $556,000 USD -96%
Research and Development Expense $23,517,000 USD -75%
Costs and Expenses $52,335,000 USD -71%
Operating Income (Loss) $45,895,000 USD 69%
Nonoperating Income (Expense) $2,943,000 USD -44%
Income Tax Expense (Benefit) $90,000 USD 67%
Net Income (Loss) Attributable to Parent $183,452,000 USD -179%
Earnings Per Share, Basic 45.37 USD/shares 30%
Earnings Per Share, Diluted 45.37 USD/shares 30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $47,872,000 USD -5.2%
Accounts Receivable, after Allowance for Credit Loss, Current $216,000 USD -55%
Inventory, Net $3,743,000 USD 19%
Other Assets, Current $1,121,000 USD -1.6%
Assets, Current $99,073,000 USD -50%
Property, Plant and Equipment, Net $0 USD -100%
Operating Lease, Right-of-Use Asset $0 USD -100%
Other Assets, Noncurrent $361,000 USD -74%
Assets $119,594,000 USD -44%
Accounts Payable, Current $3,745,000 USD -26%
Employee-related Liabilities, Current $3,983,000 USD -14%
Accrued Liabilities, Current $20,183,000 USD -67%
Contract with Customer, Liability, Current $5,314,000 USD -81%
Liabilities, Current $29,242,000 USD -78%
Contract with Customer, Liability, Noncurrent $573,000 USD -100%
Operating Lease, Liability, Noncurrent $0 USD -100%
Other Liabilities, Noncurrent $82,000 USD -90%
Liabilities $115,119,000 USD -71%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,182,000 USD 62%
Retained Earnings (Accumulated Deficit) $1,706,047,000 USD 9.7%
Stockholders' Equity Attributable to Parent $30,038,000 USD 87%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $17,005,000 USD 92%
Liabilities and Equity $119,594,000 USD -44%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,719,000 USD
Net Cash Provided by (Used in) Financing Activities $88,000 USD 47%
Net Cash Provided by (Used in) Investing Activities $51,276,000 USD -50%
Common Stock, Shares Authorized 225,000,000 shares 0%
Common Stock, Shares, Issued 4,047,000 shares 0.25%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,022,000 USD
Deferred Tax Assets, Valuation Allowance $387,555,000 USD -14%
Deferred Tax Assets, Gross $387,565,000 USD -14%
Operating Lease, Liability $2,000,000 USD -98%
Depreciation $318,000 USD -61%
Payments to Acquire Property, Plant, and Equipment $16,000 USD -45%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $187,002,000 USD -179%
Property, Plant and Equipment, Gross $0 USD -100%
Operating Lease, Liability, Current $0 USD -100%
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -100%
Deferred Tax Assets, Operating Loss Carryforwards $173,195,000 USD -16%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 125,000,000 shares 0%
Unrecognized Tax Benefits $74,500,000 USD 0.27%
Additional Paid in Capital $1,677,179,000 USD 0.51%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $10,000 USD -50%
Interest Expense $8,759,000 USD 6.2%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%